Medical Marijuana, Inc. Announces CEO Dr. Stuart Titus as Speaker at Autism Tree Project Foundation 3rd Annual Neuroscience Conference

SAN DIEGO, Oct. 25, 2017 — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that CEO Dr. Stuart Titus will be speaking on the CBD oil panel at the Autism Tree Project Foundation 3rd Annual Neuroscience Conference, being held at the Sanford Consortium from 10:45 a.m. to 12:00 p.m. on Thursday October 26, 2017.

Dr. Titus will be speaking on the panel with Dr. Keith Vaux and Audrey Kerger about the results of CBD oil use in autism patients how these results have the capacity to expand current research on autism, and how the future treatment of autism disorders could be. Other medical doctors, neuroscientists, and field experts will also be presenting on various panels and presentations throughout the day.

“We are extremely proud and thankful to be participating in such an important field of study,” said Dr. Titus. “We are confident that with our extensive background and knowledge in the field of cannabis and cannabidiol research that the audience will be informed with the most up-to-date and thorough information possible, in addition to the clinical data on both the botanical as well as pharmaceutical side. Those interested in exploring cannabidiol products will greatly benefit from this informative panel.”

Those interested in speaking with Dr. Stuart Titus about his research on the CBD oil use are encouraged to stop by the HempMeds table to speak with him or a company representative.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.


Public Relations Contact:

Andrew Hard

Chief Executive Officer

CMW Media

P: 888-829- 0070

[email protected]